We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Cholesterol Introduced to Concentrated Reagent Chemistry Portfolio

By LabMedica International staff writers
Posted on 29 Jan 2010
Introduction of cholesterol to a chemistry concentrated reagent portfolio will result in reduced turnaround times and increased productivity for high throughput labs.

Cholesterol is the 15th Advia chemistry reagent in a concentrated format. More...
The chemistry concentrated reagents offer up to 3060 tests per wedge, whilst giving identical results to conventional Advia nonconcentrated reagents.

Siemens Healthcare (Erlangen, Germany) introduced the concentrated cholesterol reagent--the 15th Advia chemistry reagent in a concentrated format. Concentrated reagent wedges liberate space on the reagent carousel, allowing laboratories to extend testing repertoire. The consolidation of tests onto the high throughput routine Advia chemistry analyzer is the factor that reduces the turnaround times and increases the laboratory's processing efficiency.

"Fast and predictable turnaround times are both essential requirements of pathology services in the UK," said Ibti Rashid, product manager for clinical chemistry at Siemens Healthcare Diagnostics.

The Siemens Healthcare sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in laboratory diagnostics, medical imaging, medical information technology, and hearing aids. By optimizing clinical workflows for the most common diseases, the company makes healthcare faster, better, and more cost-effective.

Related Links:

Siemens Healthcare




Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.